Search - tctmd.com

Displaying 721 - 740 of 881

Sort: Relevancy | Date

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

Presentation TCT 2012

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Presenter: Vivek Reddy

October 25, 2012

Presentation TCT 2012

Lone Surgical Treatment of Atrial Fibrillation: Meaningful Progress in the Past 15 Years?

Presenter: William Cohn

October 24, 2012

Presentation TCT 2012

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

Strategies for the ACS Patient with Chronic Atrial Fibrillation

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

News Daily News

French Registry: Women with STEMI Fare Worse Than Male Counterparts

October 23, 2012

Presentation TCT 2012

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

Presenter: Josep Rodes-Cabau

October 22, 2012

News Daily News

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

October 19, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

Presentation

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Presenter: Francesco Dentali

October 18, 2012

News Daily News

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Yael L. Maxwell

October 12, 2012

Advertisement

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Lone Surgical Treatment of Atrial Fibrillation: Meaningful Progress in the Past 15 Years?

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Registries Show TAVR Evolution in UK, Internationally

Strategies for the ACS Patient with Chronic Atrial Fibrillation

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

French Registry: Women with STEMI Fare Worse Than Male Counterparts

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Efficacy and Safety of the Novel Oral Anticoagulants in A-Fib: A Systematic Review and Meta-Analysis

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content